HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New inhaled drug aims to stop lung infections in vulnerable blood cancer patients
Disease control Recruiting nowThis study tests an experimental inhaled drug called PUL-042 in 100 people with blood cancers or who have had a stem cell transplant and have a viral lung infection. Participants receive either the drug or a placebo three times over six days. The goal is to see if PUL-042 can red…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Phase: PHASE2 • Sponsor: Pulmotect, Inc. • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
New drug may keep leukemia away after transplant
Disease control Recruiting nowThis study tests whether a drug called ivosidenib can help prevent acute myeloid leukemia (AML) from coming back after a stem cell transplant. About 75 adults with a specific IDH1 gene mutation will receive either ivosidenib or a placebo daily for up to two years. The goal is to …
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC